机译:慢性乙型肝炎临床试验的设计和终点指导 - 2019年EASL-AASLD HBV治疗终点会议的报告
Hannover Med Sch Dept Gastroenterol Hepatol &
Endocrinol Hannover Germany;
Univ Michigan Div Gastroenterol &
Hepatol Ann Arbor MI 48109 USA;
Univ Southern Calif Keck Med Div Gastrointestinal &
Liver Dis Los Angeles CA USA;
Univ Lyon INSERM U1052 Hosp Civils Lyon Hepatol Dept Lyon France;
Univ Hosp Leipzig Clin Gastroenterol Sect Hepatol Leipzig Germany;
Univ Pisa Dept Clin &
Expt Med Pisa Italy;
BfArM Fed Inst Drugs &
Med Devices Bonn Germany;
Hosp Univ Valle Hebron Liver Unit Barcelona 08021 Spain;
Chinese Univ Hong Kong Dept Med &
Therapeut Hong Kong Peoples R China;
Univ Penn Perelman Sch Med Med Res Dept Med Corporal Michael J Crescenz VA Med Ctr Div Gastro;
Univ Med Ctr Hamburg Eppendorf Dept Med 1 Hamburg Germany;
Kings Coll Hosp London London England;
Toronto Gen Hosp Toronto Ctr Liver Dis Toronto ON Canada;
Univ Parma Unit Infect Dis &
Hepatol Dept Med &
Surg Parma Italy;
NIDDK Liver Dis Branch NIH Bethesda MD 20892 USA;
Univ Toronto Toronto Gen Hosp Toronto ON Canada;
Barts &
London Queen Marys Sch Med &
Dent Barts Liver Ctr Blizard Inst London England;
Univ Milan CRC AM &
A Migliavacca Ctr Study Liver Dis Div Gastroenterol &
Hepatol Fdn IRCCS Ca;
NIDDK Liver Dis Branch NIH Bethesda MD 20892 USA;
Victorian Infect Dis Labs Melbourne Vic Australia;
UCL Div Infect &
Immun London England;
US FDA Div Antiviral Prod Ctr Drug Evaluat &
Res Rockville MD 20857 USA;
Natl &
Kapodistrian Univ Athens Gen Hosp Athens Laiko Dept Gastroenterol Med Sch Athens Greece;
Univ Hamburg IFI Inst Asklepios Klin St Georg Hamburg Hamburg Germany;
US FDA Rockville MD 20857 USA;
RWJ Barnabas Hlth St Barnabas Med Ctr W Orange NJ USA;
Univ Duisburg Essen Essen Univ Hosp Duisburg Germany;
Hepatitis D; Hepatitis B surface antigen; Antiviral therapy; Immunomodulatory therapy; Nucleos(t)ide analogues; CpAM;
机译:慢性乙型肝炎临床试验的设计和终点指导 - 2019年EASL-AASLD HBV治疗终点会议的报告
机译:慢性乙型肝炎临床试验的设计和终点指南 - 2019年EASL-AASLD HBV治疗终点会议的报告
机译:2019年EASL-AASLD HBV治疗终点会议上的慢性乙型肝炎慢性乙型肝炎临床试验设计和终点指南
机译:死亡:简单的临床试验端点
机译:具有连续终点的II期临床试验的预测概率中期设计
机译:研究者报告的冠心病患者随机对照试验中临床终点裁决过程的前瞻性研究的基础和设计:GLOBAL LEADERS Adjudication Sub-StudY(GLASSY)
机译:慢性乙型肝炎临床试验的设计和终点指南 - 2019年EASL-AASLD HBV治疗终点会议的报告
机译:批准非小细胞肺癌药物和生物制剂的临床试验终点:工业指南。